HomeBALAXI • NSE
add
Balaxi Pharmaceuticals Ltd
Previous close
₹575.35
Day range
₹574.75 - ₹596.00
Year range
₹399.95 - ₹686.30
Market cap
6.46B INR
Avg Volume
8.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 607.85M | -29.79% |
Operating expense | 172.45M | -7.99% |
Net income | 135.94M | 65.19% |
Net profit margin | 22.36 | 135.37% |
Earnings per share | — | — |
EBITDA | 136.17M | -10.54% |
Effective tax rate | 4.76% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 281.43M | 167.53% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 1.55B | — |
Shares outstanding | 10.23M | — |
Price to book | 3.79 | — |
Return on assets | — | — |
Return on capital | 18.91% | — |
Cash Flow
Net change in cash
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 135.94M | 65.19% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1942
Website
Employees
51